|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/5406 | (2013.01) |
| A61K 47/66 | (2017.01) | ||
| A61K 47/42 | (2017.01) | ||
| C07K 14/195 | (2013.01) | ||
| A61K 47/68 | (2017.01) | ||
| C07K 14/4747 | (2013.01) | ||
| A61P 25/00 | (2006.01) | ||
| C07K2319/55 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 25/00 | (2018.01) | ||
| C07K 14/195 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| C07K 14/47 | (2006.01) | ||
| C07K2319/00 | (2013.01) | ||
| C07K 14/54 | (2006.01) | ||
| A61K 9/0012 | (2013.01) | ||
| A61K 38/164 | (2013.01) | ||
| C07K 14/76 | (2006.01) | ||
| C07K 19/00 | (2006.01) |
| (11) | Number of the document | 3694558 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18865485.9 |
| Date of filing the European patent application | 2018-10-10 | |
| (97) | Date of publication of the European application | 2020-08-19 |
| (45) | Date of publication and mention of the grant of the patent | 2024-04-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2018/001284 |
| Date | 2018-10-10 |
| (87) | Number | WO 2019/073299 |
| Date | 2019-04-18 |
| (30) | Number | Date | Country code |
| 201762570578 P | 2017-10-10 | US |
| (72) |
MERCHANT, Fahar , CA
|
| (73) |
Medicenna Therapeutics Inc. ,
200-1920 Youge Street, Toronto, ON M4S 3E2,
CA
|
| (54) | IL-4-FUSION FORMULATIONS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM (CNS) TUMORS |
| IL-4-FUSION FORMULATIONS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM (CNS) TUMORS |